KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Share-based Compensation (2016 - 2026)

Biogen has reported Share-based Compensation over the past 18 years, most recently at $84.0 million for Q1 2026.

  • For Q1 2026, Share-based Compensation rose 3.7% year-over-year to $84.0 million; the TTM value through Mar 2026 reached $293.8 million, down 1.87%, while the annual FY2025 figure was $290.8 million, 0.14% changed from the prior year.
  • Share-based Compensation for Q1 2026 was $84.0 million at Biogen, up from $59.6 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $84.0 million in Q1 2026 and troughed at $54.9 million in Q4 2023.
  • A 5-year average of $69.7 million and a median of $71.5 million in 2023 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: skyrocketed 36.79% in 2024 and later fell 20.64% in 2025.
  • Year by year, Share-based Compensation stood at $67.2 million in 2022, then dropped by 18.3% to $54.9 million in 2023, then skyrocketed by 36.79% to $75.1 million in 2024, then dropped by 20.64% to $59.6 million in 2025, then skyrocketed by 40.94% to $84.0 million in 2026.
  • Business Quant data shows Share-based Compensation for BIIB at $84.0 million in Q1 2026, $59.6 million in Q4 2025, and $75.3 million in Q3 2025.